ISIN | CH0226274212 |
---|---|
Valor Number | 22627421 |
Bloomberg Global ID | UBANF US |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland hUSD ETF USD dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The UBS ETF (CH) – MSCI Switzerland 100% hedged to USD is an exchange traded fund incorporated in Switzerland. The objective of the Fund is to deliver the net total return performance of the MSCI Switzerland 100% hedged to USD and allow intraday trading. |
Peculiarities |
Current Price * | 29.09 USD | 02.10.2025 |
---|---|---|
Previous Price * | 28.91 USD | 01.10.2025 |
52 Week High * | 29.09 USD | 02.10.2025 |
52 Week Low * | 24.25 USD | 09.04.2025 |
NAV * | 29.09 USD | 02.10.2025 |
Issue Price * | 29.09 USD | 02.10.2025 |
Redemption Price * | 29.09 USD | 02.10.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 457,900,819 | |
Unit/Share Assets *** | 457,900,819 | |
Trading Information SIX |
YTD Performance | +13.69% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
---|---|---|
YTD Performance (in CHF) | -0.11% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
1 month | +3.15% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
3 months | +4.59% |
02.07.2025 - 02.10.2025
02.07.2025 02.10.2025 |
6 months | +3.20% |
02.04.2025 - 02.10.2025
02.04.2025 02.10.2025 |
1 year | +10.10% |
02.10.2024 - 02.10.2025
02.10.2024 02.10.2025 |
2 years | +29.68% |
12.10.2023 - 02.10.2025
12.10.2023 02.10.2025 |
3 years | +47.40% |
03.10.2022 - 02.10.2025
03.10.2022 02.10.2025 |
5 years | +56.81% |
02.10.2020 - 02.10.2025
02.10.2020 02.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 02.10.2025 |
Novartis AG Registered Shares | 13.17% | |
---|---|---|
Nestle SA | 13.03% | |
Roche Holding AG | 12.63% | |
UBS Group AG Registered Shares | 7.14% | |
ABB Ltd | 6.22% | |
Zurich Insurance Group AG | 5.74% | |
Compagnie Financiere Richemont SA Class A | 5.64% | |
Swiss Re AG | 3.04% | |
Lonza Group Ltd | 2.56% | |
Holcim Ltd | 2.38% | |
Last data update | 30.09.2025 |
TER | 0.25% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |